Imugene Limited
IUGNF
$0.1741
-$0.0073-4.02%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -85.24M | -91.89M | -98.19M | -78.37M | -58.76M |
Total Depreciation and Amortization | 3.48M | 3.06M | 2.62M | 2.05M | 1.49M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 20.56M | 24.43M | 28.26M | 23.27M | 18.35M |
Change in Net Operating Assets | 2.20M | 2.20M | 2.20M | 1.24M | 278.20K |
Cash from Operations | -59.00M | -62.19M | -65.11M | -51.82M | -38.64M |
Capital Expenditure | -6.69M | -5.70M | -4.62M | -4.83M | -5.04M |
Sale of Property, Plant, and Equipment | 947.60K | 947.60K | 947.60K | 476.50K | 6.50K |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -3.17M | -2.94M | -2.63M | -3.75M | -4.85M |
Cash from Investing | -8.91M | -7.69M | -6.30M | -8.11M | -9.89M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -1.83M | -1.69M | -1.54M | -887.70K | -236.00K |
Issuance of Common Stock | 499.20K | 27.10M | 53.70M | 53.45M | 53.21M |
Repurchase of Common Stock | -- | -- | -- | -122.80K | -245.60K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 0.00 | -1.37M | -2.74M | -2.73M | -2.72M |
Cash from Financing | -878.20K | 15.66M | 32.29M | 32.47M | 32.66M |
Foreign Exchange rate Adjustments | -914.00K | -623.00K | -329.40K | 319.40K | 973.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -69.70M | -54.84M | -39.46M | -27.13M | -14.91M |